E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/15/2013 in the Prospect News Distressed Debt Daily.

Quigley net loss rises to $836,337 in March; revenue remains flat

By Jim Witters

Wilmington, Del., April 15 - Quigley Co., Inc. posted a net loss of $836,377 for March on $50,000 in revenue, according to the company's monthly operating report filed April 15 with the U.S. Bankruptcy Court for the Southern District of New York.

Those figures compare to a $617,836 net loss for February, also on $50,000 in revenue.

The company also reported cash and cash equivalents of $40,024 as of March 31, down from $136,775 at the end of February.

Quigley, a unit of New York-based Pfizer Inc., filed for bankruptcy on Sept. 3, 2004. Its Chapter 11 case number is 04-15739.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.